A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or “wet” AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used with existing wet AMD treatments…
Wilmer Eye Institute researchers have found that ‘wet’ macular degeneration patients who don’t respond well to treatment have an increased protein in their eyes and that an experimental drug can help improve vision gains. ›
Leave a reply